Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

Autor:	Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Thrombocytopenia HCV eltrombobag predictors Therapeutics. Pharmacology RM1-950
Zdroj:	Therapeutics and Clinical Risk Management, Vol Volume 15, Pp 269-274 (2019)
Druh dokumentu:	article
ISSN:	1178-203X
Popis:	Tamer A Elbedewy,1 Mohamed A Elsebaey,1 Samah A Elshweikh,1 Heba Elashry,2 Sherief Abd-Elsalam2 1Internal Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt; 2Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt Background and aims: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltrombopag therapy in patients with HCV-associated thrombocytopenia. Patients and methods: This prospective study was carried out on 130 patients with chronic HCV-associated thrombocytopenia (
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/053e15128f6a48b8aa54899dcad949c6 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.